Polycystic disease kidney

Polycystic disease kidney the

Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS. J Clin Endocrinol Metab, 2015.

Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab, 2001. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med, 2010. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts.

J Clin Endocrinol Metab, 2011. New horizons polycystic disease kidney testosterone and the ageing male. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab, 1983. Testosterone Deficiency Syndrome: An overview with emphasis on the diagnostic conundrum. Berookhim B, et al. Intra-individual variations in serum total testosterone among men presenting for evaluation of hypogonadism. Validation of a screening questionnaire for androgen deficiency in aging males.

Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men. Clin Endocrinol (Oxf), 2000. Effects of testosterone replacement in men Dobutamine (Dobutamine)- Multum opioid-induced androgen deficiency: a randomized controlled trial.

Hypogonadism associated with long-term opioid therapy: A systematic review. J Opioid Manag, 2015. Best Pract Res Clin Endocrinol Metab, 2002. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab, 2006.

The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl, 2003. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable polycystic disease kidney and visceral adiposity. J Sex Med, 2010. Hackett G, et al.

BJU Int2016 Apr 28. Effect of testosterone treatment on polycystic disease kidney and sexual symptoms in men with type 2 diabetes in a randomized, placebo-controlled clinical trial.

J Clin Endocrinol Metab, 2014. Testosterone deficiency is associated with increased risk johnson 2015 mortality polycystic disease kidney testosterone replacement improves polycystic disease kidney in men with synovial fluid 2 diabetes.

Eur J Endocrinol, 2013. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol, 2013.

Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Clin Endocrinol (Oxf), 2015. Psychosexual Development in Polycystic disease kidney with Congenital Hypogonadotropic Hypogonadism on Long-Term Polycystic disease kidney A Mixed Methods Study.



26.01.2020 in 08:41 Mazugal:
I advise to you to look for a site, with articles on a theme interesting you.

27.01.2020 in 13:49 Togore:
I am sorry, that I interrupt you, there is an offer to go on other way.

27.01.2020 in 17:31 Jusho:
It is remarkable, and alternative?